We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

544 hedge funds and large institutions have $2.01B invested in iShares US Medical Devices ETF in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 152 increasing their positions, 224 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $12.7M

3.75% more ownership

Funds ownership: 35.74%39.49% (+3.8%)

7% less funds holding

Funds holding: 585544 (-41)

8% less capital invested

Capital invested by funds: $2.19B → $2.01B (-$185M)

32% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 224

40% less funds holding in top 10

Funds holding in top 10: 159 (-6)

46% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 80

Holders
544
Holders Change
-41
Holders Change %
-7.01%
% of All Funds
8.63%
Holding in Top 10
9
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-40%
% of All Funds
0.14%
New
43
Increased
152
Reduced
224
Closed
80
Calls
$18.6M
Puts
$12.7M
Net Calls
+$5.93M
Net Calls Change
+$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
GPA
151
Garrison Point Advisors
California
$1.59M -$22K -414 -1%
MAP
152
Milestone Advisory Partners
North Carolina
$1.59M +$187K +3,516 +12%
IAN
153
Integrated Advisors Network
Texas
$1.58M -$28K -526 -2%
DWM
154
Destination Wealth Management
California
$1.56M -$10.4K -195 -0.6%
CWM
155
C2C Wealth Management
Arizona
$1.56M
Mirae Asset Global Investments
156
Mirae Asset Global Investments
South Korea
$1.55M
SS
157
Sunbelt Securities
Texas
$1.52M -$162K -3,055 -9%
YAVAPFMC
158
Yahav Achim Ve Achayot - Provident Funds Management Company
Israel
$1.51M
CA
159
Cetera Advisors
Colorado
$1.51M -$44.7K -841 -3%
ASN
160
Advisory Services Network
Georgia
$1.51M +$125K +2,359 +8%
CBFP
161
Cedar Brook Financial Partners
Ohio
$1.48M +$22.7K +427 +1%
FAIM
162
Financial Advocates Investment Management
Washington
$1.47M -$1.26M -23,787 -45%
IFG
163
Independent Financial Group
California
$1.47M +$394K +7,412 +32%
ACM
164
AlphaStar Capital Management
North Carolina
$1.47M +$765K +14,394 +106%
Jane Street
165
Jane Street
New York
$1.45M +$1.37M +25,758 +614%
WWA
166
WCG Wealth Advisors
Nevada
$1.45M +$1.59M +29,925 New
AFP
167
Ausdal Financial Partners
Iowa
$1.45M +$798 +15 +0.1%
IFWM
168
Institute for Wealth Management
Colorado
$1.45M +$32.1K +604 +2%
IWM
169
IHT Wealth Management
Illinois
$1.44M -$1.17K -22 -0.1%
MA
170
Mutual Advisors
Nebraska
$1.43M -$77.7K -1,461 -5%
CW
171
CIC Wealth
Maryland
$1.42M -$15.4K -290 -1%
NS
172
NBC Securities
Alabama
$1.31M +$1.44M +26,992 New
FTUS
173
Flow Traders U.S.
New York
$1.3M +$332K +6,253 +30%
PSF
174
Pacific Sun Financial
California
$1.27M +$49.1K +923 +4%
RFC
175
Regions Financial Corp
Alabama
$1.26M -$27.3K -513 -2%

IHI Hedge Fund Activity: Q3 2023 in Review

544 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q3 2023, worth a combined $2.01B — down 8.4% from $2.19B a quarter earlier.

Sellers outnumbered buyers: 80 funds closed out of IHI and 43 opened new positions — a net loss of 37 holders — while 224 trimmed existing stakes and 152 added.

The largest buyer was Bank of America, adding an estimated $50.2M. The largest seller was Morgan Stanley, cutting an estimated $34.4M.

  • 544 institutional investors held iShares US Medical Devices ETF (IHI) as of Q3 2023, down from 585 in Q2 2023.
  • Funds reported $2.01B of iShares US Medical Devices ETF stock for Q3 2023, down 8.4% quarter-over-quarter.
  • 43 funds opened new iShares US Medical Devices ETF positions in Q3 2023 and 80 closed out, a net change of -37 holders.
  • The largest iShares US Medical Devices ETF buyer in Q3 2023 was Bank of America, an estimated $50.2M added.
  • The largest iShares US Medical Devices ETF seller in Q3 2023 was Morgan Stanley, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2023.